Isofol Medical’s Board of Directors intends to call an extraordinary general meeting with proposals for dividends and liquidation of the company
GOTHENBURG, Sweden, January 19, 2023 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), decided today to call an extraordinary general meeting to take a decision on a cash dividend of the maximum amount of capital available and to decide that the company is to be liquidated. The assessment is based on a thorough analysis of Isofol's future opportunities after the negative outcome of the company's phase III study (AGENT) and aims to ensure that as large a part of the company's remaining assets as possible benefit the shareholders.The information in the press release is intended for